Concepedia

Heidi M. Ferguson

HM

16

Publications

632

Citations

14

H-Index

2010

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of California, San Francisco

University of California, Berkeley

Quantitative BioSciences

Heidi M. Ferguson is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and engineering.

ORCID

Top concepts

Publications per year

2010–2021

16

Publications

16

Design, Synthesis, and Biological Evaluation of a Robust, Biodegradable Dendrimer

Derek G. van der Poll, Heidi M. Ferguson, William C. Floyd et al. · Bioconjugate Chemistry · 2010 · 99 citations

Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors

Qinglin Pu, Hongjun Zhang, Liangqin Guo et al. · ACS Medicinal Chemistry Letters · 2020 · 82 citations · Full text

Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity

Yanxia Guo, Kenzie D. MacIsaac, Yi Chen et al. · Cell Reports · 2016 · 58 citations · Full text

Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan

Kareen Riviere, Heidi M. Ferguson, Katherine Jerger et al. · Journal of Controlled Release · 2011 · 50 citations · Full text

, , +5

Combination of EP <sub>4</sub> antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells

Yun Wang, Long Cui, Peter Georgiev et al. · OncoImmunology · 2021 · 48 citations · Full text

Rows per page

1–5 of 16